Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Bioarctic Ab

Clinical trials sponsored by Bioarctic Ab, explained in plain language.

BioArctic AB BIOA-B NASDAQ STOCKHOLM

Swedish biopharmaceutical company developing treatments for neurodegenerative diseases.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 1

New drug trial aims to tame Parkinson's and MSA

Disease control Ongoing

This study tests a new medicine called exidavnemab in people with mild to moderate Parkinson's disease or multiple system atrophy. The main goal is to check if the drug is safe and how the body processes it. Participants will receive either the drug or a placebo, and researchers …

Phase: PHASE2 • Sponsor: BioArctic AB • Aim: Disease control

Last updated Jun 27, 2026 11:00 UTC